Back
Ultragenyx Pharmaceutical Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
RARE
Ultragenyx Pharmaceutical
Last Price:
$35.13
Seasonality Move:
14.41%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.74 | Sell |
| 20-day SMA: | 38.27 | Sell |
| 50-day SMA: | 41.21 | Sell |
| 200-day SMA: | 46.92 | Sell |
| 8-day EMA: | 36.41 | Sell |
| 20-day EMA: | 38.14 | Sell |
| 50-day EMA: | 40.54 | Sell |
| 200-day EMA: | 44.83 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 35.12 | Sell |
| Chaikin Money Flow: | 269243 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.87 - 41.01) | Sell |
| Bollinger Bands (100): | (39.72 - 47.1) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 35.13 while RARE 8-day simple moving average is 36.74, which is a Sell signal.
-
The stock price of RARE is 35.13 while Ultragenyx Pharmaceutical 20-day SMA is 38.27, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 41.21 while RARE share price is 35.13, making it a Sell technically.
-
RARE stock price is 35.13 and Ultragenyx Pharmaceutical 200-day simple moving average is 46.92, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
11
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $35.13. The Score for RARE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.2B
Price in USD:
35.13
Share Volume:
631.8K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
33.53
Sell
11
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 35.13 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 35.13 while RARE 8-day exponential moving average is 36.41, which is a Sell signal.
-
The stock price of RARE is 35.13 while Ultragenyx Pharmaceutical 20-day EMA is 38.14, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 40.54 while RARE share price is 35.13, making it a Sell technically.
-
RARE stock price is 35.13 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.83, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.81 per share, and an increase next year of $1.90 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is -1.64, suggesting Ultragenyx Pharmaceutical is a Sell
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 35.12, which suggest Ultragenyx Pharmaceutical is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (36.87 - 41.01), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (39.72 - 47.1), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.